CAMP4 Therapeutics is a clinical-stage biotechnology company harnessing the power of RNA to address genetic diseases characterized by decreased protein expression. CAMP4’s RAP Pla…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
CAMP4 Therapeutics is a clinical-stage biotechnology company harnessing the power of RNA to address genetic diseases characterized by decreased protein expression. CAMP4’s RAP Pla…
Details are not available yet. The company remains listed.
Ensoma is an in vivo hematopoietic stem cell (HSC) engineering company focused on creating a new kind of genomic medicine that treats diseases with a one-time treatment regimen by…
NodThera is a biotech company focused on developing therapies that target the NLRP3 inflammasome to treat chronic inflammatory diseases at their source.
Karius is a company focused on architecture, offering various architectural services and projects.
TMRW® Life is a platform connecting hotel operations and guests, enhancing hotel management through mobile applications.
Rallybio is a clinical-stage biotech company committed to delivering groundbreaking therapies with the potential to truly transform the lives of millions of patients with devastat…
Surrozen is pioneering therapies that harness the power of Wnt signaling to treat sight-threatening ophthalmic conditions. The company develops multi-target antibody therapeutics…
Details are not available yet. The company remains listed.
Homology Medicines, Inc. is a biotechnology company focused on developing genetic medicines to treat and cure rare genetic diseases through gene editing and gene therapy.
Crinetics is a global pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors.
Aprea Therapeutics is a clinical-stage biopharmaceutical company focused on developing DDR-targeted therapies for cancer treatment, aiming to exploit specific vulnerabilities in c…
IDEAYA is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapeutics for cancer, particularly through synthetic lethali…
A clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases.
RareCyte is a Precision Biology company specializing in spatial biology and liquid biopsy solutions, providing advanced platforms and expert services for high-resolution insights…
Impel NeuroPharma is a late-stage pharmaceutical company focused on utilizing proprietary technology to develop and commercialize transformative therapies for patients suffering f…
Expansion Therapeutics is a biotech firm focused on developing treatments for RNA-mediated diseases, securing $80 million in Series B funding in 2021. The company aims to create o…
GlycoEra is focused on developing biologics to selectively target and degrade specific circulating proteins, particularly autoantibodies, that drive autoimmune diseases. Their inn…
Details are not available yet. The company remains listed.
Mendra is a biopharmaceutical company focused on improving the development and commercialization of rare disease therapies worldwide, utilizing AI to address challenges in patient…
Precede Biosciences is a precision diagnostics and data company redefining what can be learned from a simple blood draw. By unlocking genome-wide transcriptional biology through a…
Kinaset Therapeutics is focused on developing inhaled therapeutics to address significant unmet medical needs in respiratory diseases. Their lead clinical candidate, frevecitinib…
Fellow is an AI meeting assistant designed to record, transcribe, and summarize meetings with a focus on privacy and security. It integrates with various platforms and automates C…
Lifordi is among the first companies to leverage the success of antibody-drug conjugates (ADC) in oncology to develop treatments for autoimmune and inflammatory disorders. They fo…
Prolynx is a biotechnology company dedicated to developing ultra-long-acting medicines for obesity and other metabolic diseases. The Company is advancing a proprietary portfolio o…
Bioz is the world's most advanced AI search engine for scientific experimentation, empowering scientists in biopharma and academia to accelerate their research towards new discove…
Curie.bio is a venture capital firm that helps founders discover and develop important new medicines by providing funding and operational support to early-stage therapeutics compa…
Faraday Defense designs and manufactures high-performance shielding solutions, including Faraday bags, enclosures, and textiles for protecting devices and data from wireless intru…
Renasant Bio is pioneering a new approach to treating autosomal dominant polycystic kidney disease (ADPKD) by developing small molecule correctors and potentiators that target the…
A clinical-stage biopharma company based in California, focused on therapies for CNS disorders. The company employs proprietary technologies including optogenetics, STARmap and tr…
scPharmaceuticals specializes in cardiovascular and renal therapies, focusing on late-stage biotech commercialization. They provide tailored solutions for R&D companies seeking to…
Scientist.com is a marketplace that connects scientists with service providers to facilitate research and development in various fields, including life sciences and biotechnology.
Arvinas is a biotechnology company focused on developing innovative therapies using its proprietary PROTAC protein degradation platform, aiming to transform drug discovery and imp…
Miikana Therapeutics appears to be a therapeutics company, but the available search results provide no reliable details about its products, disease focus, business model, or techn…
Biotechnology company developing therapies for endocrine diseases, including oral small-molecule candidates for Prader-Willi syndrome, congenital adrenal hyperplasia, and Cushing’…
Achaogen is focused on developing innovative antibiotics for the treatment of serious infections caused by multi-drug resistant bacteria, particularly in the area of complicated u…
Biotechnology company developing precision genetic therapies intended to restore, improve, and preserve hearing, including treatments targeting hearing loss through inner-ear gene…
Alexza Pharmaceuticals, Inc. is a pharmaceutical company. The provided search results identify the company but do not describe its products or technologies.
Ambrx Biopharma Inc. is a clinical stage biopharmaceutical company that utilizes an expanded genetic code technology platform to create Engineered Precision Biologics (EPBs), focu…
Biotechnology company developing gene therapy products for patients with diseases caused by single-gene defects, including rare neuromuscular, metabolic, and cardiac disorders. It…
Clinical-stage biotherapeutics company developing drug-device products for cardiopulmonary and cardiac diseases. Its INOpulse platform delivers inhaled nitric oxide through a port…
Clinical-stage biopharmaceutical company developing therapeutic antibodies that target immuno-inflammatory regulators, leveraging biologic targets with human proof of mechanism.
Calibrium was a biopharmaceutical company developing novel peptide drug candidates for diabetes, obesity, and related metabolic diseases. Novo Nordisk acquired the company in 2015.
The search results do not provide reliable information about Cellular Research. The detailed biotech profile describes Cypre, Inc., a separate company, so its products and activit…
Developer of minimally invasive arthroscopic surgical instruments, including the NovoStitch Pro system for repairing complex meniscal tears in knees and other joints. Acquired by…
Chrono Therapeutics is focused on improving clinical outcomes for patients battling addictions and living with neurological disorders via our proprietary Digital Patch platform, p…
Biopharmaceutical company developing antiviral and antifungal therapies, including long-acting influenza prevention and treatments for invasive fungal infections. Its programs inc…
CinCor Pharma is a clinical-stage biopharmaceutical company focused on developing innovative treatments for cardiovascular and renal diseases, particularly through its lead produc…
A fully integrated AI platform optimizing eCommerce from acquisitions to fulfillment.
Developer and manufacturer of high-parameter single-cell analysis systems, reagents, and software for life sciences research. Its CyTOF mass cytometry platform uses metal-tagged a…
Enliven Health is transforming how pharmacies deliver clinical care through innovative clinical solutions, focusing on enhancing pharmacy operations and patient care.
Epirus is dedicated to overcoming the asymmetric challenges inherent to the future of national security, utilizing advanced technologies like high-power microwave systems for elec…
Escient is an organizational growth and transformation consultancy focused on human-centered organizational design, culture, leadership resilience, customer experience, sustainabi…
Flexion builds adaptable software systems that turn complex, uncertain challenges into opportunities. They partner with leaders to build software systems that evolve as priorities…
Halio develops electrochromic smart glass and an integrated daylight-management system for buildings. Its smart windows dynamically tint in response to user preferences and weathe…
Igenica Biotherapeutics was a biotechnology company focused on discovering and developing antibody-based therapeutics, particularly for oncology and immunotherapy. The search resu…
Ikaria, Inc. is now a part of Mallinckrodt Pharmaceuticals, focusing on pharmaceutical manufacturing and medical imaging products.
A therapeutics platform spinout of Symyx that developed novel polymer-based, orally bioavailable therapies for renal failure and metabolic disorders. Acquired by Amgen.
Middle-market private equity firm investing in U.S. and Canadian companies with enterprise values of $25 million to $750 million. It targets services, value-added distribution, so…
Inipharm is a clinical-stage biopharmaceutical company focused on discovering and developing therapies for severe liver diseases, particularly through small-molecule inhibitors ta…
Biopharmaceutical company developing therapeutic antibody medicines using its proprietary Humaneering antibody-engineering platform. Its pipeline included antibody candidates for…
Latigo Biotherapeutics is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the tran…
Magnetic Insight introduces magnetic particle imaging, a groundbreaking imaging technology addressing today's clinical and translational research challenges. This technology allow…
Biopharmaceutical drug-development company focused on therapeutic products for diabetes, obesity, and other metabolic diseases. Its pipeline included peptide-based drug candidates…
nChroma Bio is a genetic medicines company committed to addressing the limitations of existing therapies through a disease-first approach. By combining programmable in vivo delive…
Neurogastrx is a privately held, late clinical-stage biopharmaceutical company focused on identifying and developing therapies for patients suffering from serious gastrointestinal…
Biotechnology company developing precision medicines for severe neurological and neuromuscular diseases. It uses human genetics and a functional genomics discovery platform based…
Novira is a Central European investment and real estate group with a portfolio spanning commercial and residential property, startup investments, and financing services. It also s…
Panomics provides an enterprise AI platform for managing, analyzing, and exploring omics research data. The platform supports sample and metadata management, multimodal data analy…
Pear is an Australian consulting platform that matches companies with vetted ex-top-tier management consultants and boutique consulting firms, typically within 48 hours, at the lo…
Pearl is a leader in dental AI, providing innovative solutions to enhance dental practices through advanced technology.
Biotechnology company developing RNA nanomedicines and mRNA therapeutics for rare inherited diseases, particularly life-threatening liver diseases and urea cycle disorders in chil…
Develops software-defined drug delivery devices for biologics, including needle-free injection technology and reusable, software-controlled auto-injectors customized to medication…
Precision NanoSystems is a global leader in technologies, solutions, and services to support nanomedicine development for genomic medicine applications, including mRNA vaccines an…
Clinical-stage biopharmaceutical company developing inhaled therapies for serious pulmonary diseases and central nervous system disorders. Its proprietary iSPERSE engineered dry-p…
Purigen Biosystems develops automated benchtop systems and kits for extracting, enriching, and quantifying DNA and RNA from biological samples. Its Ionic Purification System uses…
Clinical-stage biopharmaceutical company discovering and developing small-molecule radiopharmaceuticals for precision treatment and imaging of solid tumors. Its platform uses AI-d…
Biopharmaceutical company developing non-absorbed polymeric drugs for cardiovascular and renal diseases. Its lead product, VELTASSA (patiromer), binds potassium in the gastrointes…
Specialty chemicals company developing catalytic processes to produce chemicals such as glucaric acid, adipic acid, 1,6-hexanediol, and hexamethylenediamine from renewable feedsto…
Provides dedicated long-term offsite cryostorage, specimen logistics, and biorepository services for reproductive tissues, supporting fertility clinics and patients with secure st…
Clinical-stage biotechnology company developing oral NLRP3 inhibitors to reduce chronic inflammation in cardiovascular and neurological diseases. Its lead candidate, ruvonoflast,…
Semprus BioSciences develops permanently bonded, non-leaching biofunctional surface modifications for medical devices. Its platform is designed to reduce infection, thrombosis, re…
Swiss biopharmaceutical company developing and commercializing clinical-stage medicines for unmet needs in psychiatry and neurology. Its pipeline included six compounds sourced th…
Biopharmaceutical company developing prophylactic vaccines and immunotherapeutics for infectious diseases and cancer. Its virus-like particle platforms, including enveloped VLP (e…
Viveve Medical developed and commercialized medical devices for women's intimate health, including cryogen-cooled monopolar radiofrequency (CMRF) systems for vaginal health and no…
Clinical-stage biotechnology company developing targeted therapies for autoimmune diseases. Its lead program, telitacicept (TACI-Fc), is a dual BAFF/APRIL inhibitor designed to re…
Wildcat is a single-family office and thematic growth investor that partners with management teams across venture, growth, and buyout investments. Its portfolio spans digital cust…
Nouscom is a next-generation immunotherapy company developing engineered viral vectored vaccines for treatment of cancer, utilizing proprietary platforms to induce strong immune r…
Clinical-stage biotechnology company developing next-generation therapeutics for obesity and other metabolic diseases. Its lead candidate, nimacimab, is a peripherally restricted…